SHPH
NASDAQ · Biotechnology
Shuttle Pharmaceuticals Hold
$1.63
+0.06 (+3.82%)
Open$1.56
Previous Close$1.57
Day High$1.65
Day Low$1.51
52W High$24.86
52W Low$13.02
Volume—
Avg Volume357.0K
Market Cap4.37M
P/E Ratio36.06
EPS$0.48
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.31M | 2.94M | 3.37M |
| Net Income | 119.2K | 97.1K | 110.6K |
| Profit Margin | 3.6% | 3.3% | 3.3% |
| EBITDA | 181.4K | 163.4K | 177.0K |
| Free Cash Flow | 96.2K | 133.1K | 131.3K |
| Rev Growth | +15.9% | +11.7% | +12.8% |
| Debt/Equity | 0.66 | 0.73 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |